HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J acquires Chinese cosmetics

This article was originally published in The Rose Sheet

Executive Summary

Firm adds Beijing Dabao Cosmetics - whose skin-care offerings include SOD Milk Cream and SOD Protein Milk, which rely on superoxide dismutase to reduce free-radical damage - to its growing portfolio of brands sold in China. "Dabao is a successful brand in the China market, and a brand we respect," says Jesse Wu, president of Johnson & Johnson (China) Investment Co. "This transaction is an extension of our commitment to China and to the continued development of China's consumer health-care sector." J&J will develop brand with help of Dabao's "unsurpassed local market knowledge," Wu notes. J&J holdings Johnson's Baby, Neutrogena and Clean & Clear are already available to Chinese consumers. Firm is official partner of Beijing 2008 Olympic Games and Paralympic Games and has launched Johnson & Johnson Family Health Initiative in the country. All government approvals were complete at time of announcement; financial terms were not disclosed...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

RS015579

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel